Cormorant Asset Management, LP Zai Lab LTD Transaction History

Cormorant Asset Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $5.61 Million - $9.53 Million	-53,455 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$125.11 - $180.0 $12.1 Million - $17.4 Million	-96,545 Reduced 64.36%	53,455 $9.46 Million
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $4.94 Million - $7.49 Million	-39,092 Reduced 20.67%	150,000 $20 Million
Q3 2020 Nov 16, 2020	SELL	$73.3 - $89.48 $4.46 Million - $5.45 Million	-60,908 Reduced 24.36%	189,092 $15.7 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $1.91 Million - $3.23 Million	-39,092 Reduced 13.52%	250,000 $20.5 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $466,502 - $750,459	11,931 Added 4.3%	289,092 $14.9 Million
Q3 2019 Nov 14, 2019	SELL	$30.47 - $37.65 $695,904 - $859,888	-22,839 Reduced 7.61%	277,161 $8.97 Million
Q2 2019 Aug 14, 2019	SELL	$25.73 - $35.79 $1.29 Million - $1.79 Million	-50,000 Reduced 14.29%	300,000 $10.5 Million
Q1 2019 May 15, 2019	SELL	$21.71 - $31.54 $9.5 Million - $13.8 Million	-437,426 Reduced 55.55%	350,000 $10.3 Million
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $310,063 - $512,692	-20,740 Reduced 2.57%	787,426 $18.3 Million
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $8.46 Million - $12 Million	475,000 Added 142.57%	808,166 $15.7 Million
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $9 Million - $10.4 Million	333,166	333,166 $9 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.48B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.